News

NELSON: A successful early detection trial shown to reduce lung cancer mortality in (ex) smokers

NELSON: A successful early detection trial shown to reduce lung cancer mortality in (ex) smokers https://www.i-dna.org/wp-content/uploads/2020/01/Final_Lungnodules.jpg 1920 1440 iDNA iDNA //www.i-dna.org/wp-content/uploads/2020/01/NEW-No-text3-1.png 20 February 2020 20 February 2020

Having a potential impact of saving 60,000-80,000 people with lung cancer per year within Europe The scientific article ‘’Reduced Lung Cancer Mortality with Volume CT Screening in the NELSON trial”…

AGILE Conference Madrid – May 9 to May 11, 2024

AGILE Conference Madrid – May 9 to May 11, 2024 https://www.i-dna.org/wp-content/uploads/2024/03/AGILE-Conference-2024.jpg 1200 630 iDNA iDNA //www.i-dna.org/wp-content/uploads/2020/01/NEW-No-text3-1.png 28 March 2024 11 June 2024

AGILEDxRx Conference Alliance for Global Implementation of Lung and Cardiac Early Disease Detection and Treatment The first AGILEDxRx Conference will be hosted in Madrid, Spain from Thursday, May 9 to…

The Dutch Cancer Institute was the 1st center in the Netherlands to officially start the H2020 European 4-in-the-lung-run study into personalized lung cancer screening

The Dutch Cancer Institute was the 1st center in the Netherlands to officially start the H2020 European 4-in-the-lung-run study into personalized lung cancer screening https://www.i-dna.org/wp-content/uploads/2023/02/Siemens-CT-scanner_anoniem_maken-scaled.jpg 2560 1920 iDNA iDNA //www.i-dna.org/wp-content/uploads/2020/01/NEW-No-text3-1.png 1 February 2023 1 February 2023

This week, the Antoni van Leeuwenhoek (AVL) Dutch Cancer Institute will officially start as the first Dutch center with a study on personalized lung cancer screening. After an earlier pilot…

Delfi Diagnostics Selected as the Liquid Biopsy Partner for 4-IN-THE-LUNG-RUN: A Large-Scale European Lung Cancer Screening Study

Delfi Diagnostics Selected as the Liquid Biopsy Partner for 4-IN-THE-LUNG-RUN: A Large-Scale European Lung Cancer Screening Study https://www.i-dna.org/wp-content/uploads/2022/09/Reageerbuizen-scaled.jpg 2560 1707 iDNA iDNA //www.i-dna.org/wp-content/uploads/2020/01/NEW-No-text3-1.png 19 September 2022 19 September 2022

Delfi Diagnostics, a pioneering developer of a new class of high-performance, accessible liquid biopsy tests for early cancer detection and monitoring, has been selected as the liquid lung cancer biopsy…

Start of the 4-In-The-Lung-Run trial in the Netherlands

Start of the 4-In-The-Lung-Run trial in the Netherlands https://www.i-dna.org/wp-content/uploads/2020/01/Opa-en-kleinzoon-scaled.jpg 2560 1708 iDNA iDNA //www.i-dna.org/wp-content/uploads/2020/01/NEW-No-text3-1.png 17 August 2022 2 September 2022

Start of the 4-In-The-Lung-Run trial in the Netherlands We are honored to be part of the European H2020 4-In-The-Lung-Run (4ITLR) Lung Cancer Screening trial with Dutch (ErasmusMC, Dutch Cancer…

AI shows promise in significantly reducing radiologist workload

AI shows promise in significantly reducing radiologist workload https://www.i-dna.org/wp-content/uploads/2020/01/Final_Lungnodules.jpg 1920 1440 iDNA iDNA //www.i-dna.org/wp-content/uploads/2020/01/NEW-No-text3-1.png 25 January 2022 25 January 2022

New iDNA publication! iDNA and partners have published new research validating the clinical performance of AI software in the medical scientific journal Lung Cancer: “Outstanding negative prediction performance of solid…

Key Dutch publication on COVID-19 featured in Radiology special edition

Key Dutch publication on COVID-19 featured in Radiology special edition https://www.i-dna.org/wp-content/uploads/2021/02/Covid-19_MonographCover-e1612367631685.jpg 1078 1217 iDNA iDNA //www.i-dna.org/wp-content/uploads/2020/01/NEW-No-text3-1.png 3 February 2021 3 January 2022

The diagnosis, prevention and treatment on COVID-19 from April 9th is now featured in Radiology’s special edition of their most highly cited and most influential articles published during the pandemic…

Most cited paper of 2017 in European Radiology!

Most cited paper of 2017 in European Radiology! https://www.i-dna.org/wp-content/uploads/2020/08/NPS.jpg 600 400 iDNA iDNA //www.i-dna.org/wp-content/uploads/2020/01/NEW-No-text3-1.png 5 August 2020 26 August 2020

Another moment worth celebrating for iDNA! An article published in European Radiology, of which prof. Oudkerk was supervisor and co-author, has recently received the award for most cited article of…

Working to find solutions for COVID-19

Working to find solutions for COVID-19 https://www.i-dna.org/wp-content/uploads/2020/05/shutterstock_1643947495-scaled.jpg 2560 1476 iDNA iDNA //www.i-dna.org/wp-content/uploads/2020/01/NEW-No-text3-1.png 11 May 2020 29 July 2020

iDNA against COVID-19 To address the current Covid-19 challenges, the Dutch National Institute for Health and Environment (RIVM) has formally requested Prof. Oudkerk to bring together a group of key…

Less Is More in Lung Cancer Risk Prediction Models

Less Is More in Lung Cancer Risk Prediction Models https://www.i-dna.org/wp-content/uploads/2020/01/Final_Lungnodules.jpg 1920 1440 iDNA iDNA //www.i-dna.org/wp-content/uploads/2020/01/NEW-No-text3-1.png 20 February 2020 20 February 2020

In an invited commentary for JAMA Network Open, Marjolein Heuvelmans, MD, PhD, together with prof. Oudkerk, commented on current developments in the field of lung cancer screening risk prediction modelling.…

NELSON: A successful early detection trial shown to reduce lung cancer mortality in (ex) smokers

AGILE Conference Madrid – May 9 to May 11, 2024

The Dutch Cancer Institute was the 1st center in the Netherlands to officially start the H2020 European 4-in-the-lung-run study into personalized lung cancer screening

Delfi Diagnostics Selected as the Liquid Biopsy Partner for 4-IN-THE-LUNG-RUN: A Large-Scale European Lung Cancer Screening Study

Start of the 4-In-The-Lung-Run trial in the Netherlands

AI shows promise in significantly reducing radiologist workload

Key Dutch publication on COVID-19 featured in Radiology special edition

Most cited paper of 2017 in European Radiology!

Working to find solutions for COVID-19

Less Is More in Lung Cancer Risk Prediction Models

Privacy Preferences